# Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF

Study · id `cardio:ct-nct06078436` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06078436](<https://clinicaltrials.gov/study/NCT06078436>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06078436

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT06078436. Randomized; no masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT06078436, source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)
- Planned start: 2024-01 (anticipated) (ClinicalTrials.gov record NCT06078436, source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)
- Primary completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT06078436, source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT06078436, source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT06078436, source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06078436-2024-01-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
- Acronym: PACE-SHOCK
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Cardiogenic Shock
- Intervention (Device): Pulmonary artery catheter
- Lead sponsor: Min-Seok Kim
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)

## Provenance

Content hash: 2124617bc320e742c3988413efbf3545e1c9924b669c41442a11057424b6075d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
